Deutsche Bank
CALA

Deutsche Bank’s Calithera Biosciences, Inc CALA Stock Holding History

Deutsche Bank’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-22
Closed -$1K – 4772
2021
Q2 		$1K Sell
22
-2,271
-99% -$99.8K ﹤0.01% 4575
2021
Q1 		$111K Sell
2,293
-200
-8% -$11.6K ﹤0.01% 3920
2020
Q4 		$244K Sell
2,493
-6,565
-72% -$575K ﹤0.01% 3364
2020
Q3 		$625K Buy
9,058
+4,390
+94% +$383K ﹤0.01% 2499
2020
Q2 		$493K Buy
4,668
+3,785
+429% +$450K ﹤0.01% 2655
2020
Q1 		$78K Buy
883
+96
+12% +$11.4K ﹤0.01% 3351
2019
Q4 		$89K Buy
787
+162
+26% +$12.2K ﹤0.01% 3637
2019
Q3 		$37K Sell
625
-757
-55% -$60.6K ﹤0.01% 4088
2019
Q2 		$106K Sell
1,382
-665
-32% -$75.5K ﹤0.01% 4183
2019
Q1 		$274K Buy
2,047
+14
+0.7% +$1.47K ﹤0.01% 3814
2018
Q4 		$162K Sell
2,033
-2,187
-52% -$216K ﹤0.01% 3988
2018
Q3 		$443K Sell
4,220
-5,750
-58% -$548K ﹤0.01% 3847
2018
Q2 		$997K Sell
9,970
-5,810
-37% -$658K ﹤0.01% 3422
2018
Q1 		$1.99M Sell
15,780
-3,821
-19% -$596K ﹤0.01% 2875
2017
Q4 		$3.27M Buy
19,601
+11,228
+134% +$2.88M ﹤0.01% 2386
2017
Q3 		$2.64M Buy
8,373
+5,435
+185% +$1.71M ﹤0.01% 2360
2017
Q2 		$872K Buy
2,938
+2,728
+1,299% +$730K ﹤0.01% 3134
2017
Q1 		$48K Buy
+210
New +$36.3K ﹤0.01% 4241
2016
Q4 		– Sell
-2,771
Closed -$180K – 5146
2016
Q3 		$180K Buy
2,771
+1,742
+169% +$112K ﹤0.01% 3704
2016
Q2 		$76K Buy
1,029
+568
+123% +$56.9K ﹤0.01% 4237
2016
Q1 		$52K Sell
461
-56
-11% -$6.34K ﹤0.01% 4304
2015
Q4 		$78K Sell
517
-1,518
-75% -$228K ﹤0.01% 4175
2015
Q3 		$219K Sell
2,035
-4
-0.2% -$518 ﹤0.01% 3758
2015
Q2 		$289K Buy
2,039
+2,038
+203,800% +$472K ﹤0.01% 3697
2015
Q1 		$0 Buy
+1
New +$356 ﹤0.01% 6156
2014
Q4 		– Hold
0
– – – 6387

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank's CALA Position: Q3 2021 in Review

Deutsche Bank sold out of Calithera Biosciences, Inc (CALA) in Q3 2021, closing a stake of 22 shares — an estimated $1K sold.

Deutsche Bank first reported a position in CALA in Q1 2015 and held it in 25 quarters. The position peaked at $3.27M in Q4 2017. 66 funds tracked by Wall St. Rank hold CALA as of Q3 2021.

  • Deutsche Bank reported no remaining Calithera Biosciences, Inc position as of Q3 2021 after selling out during the quarter.
  • Deutsche Bank sold 22 Calithera Biosciences, Inc shares in Q3 2021, an estimated $1K.
  • Deutsche Bank first reported a position in Calithera Biosciences, Inc in Q1 2015 and held it in 25 quarters.
  • Deutsche Bank's Calithera Biosciences, Inc position peaked at $3.27M in Q4 2017.
  • 66 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2021.

Based on Deutsche Bank's 13F filing for Q3 2021, filed 4 Nov 2021.